Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PsyCARE Trial
NCT05796401Phase 3Recruiting
- Sponsor
- Centre Hospitalier Sainte-Anne
- Start
- Dec 2023
- Primary completion
- Dec 2026
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 3, randomised trial of vitamin b12, folinic acid, MAT9001 and acetylcysteine in psychosis (4 arms), sponsored by Centre Hospitalier Sainte-Anne. Primary endpoint: Global functioning. Started Dec 2023; status: recruiting.
02
Drugs
vitamin b12folinic acidMAT9001acetylcysteine
03
Conditions
psychosis
Beyond the preview
Go deeper on NCT05796401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05796401.